Tag: Evrenzo

According to the European Medicines Agency (EMA), roxadustat is a first-in-class, orally administered medication for symptomatic anemia associated with chronic kidney disease (CKD), and it is also known by other names. This article answers the question, **what is another name for roxadustat?**, and provides context on this important drug.

Affecting millions of individuals with chronic kidney disease, anemia is a common and serious complication. What is the drug roxadustat used for is to address this very issue, functioning as an oral medication that stimulates red blood cell production by mimicking the body's natural response to low oxygen levels.

First approved in China in 2018, Roxadustat (trade name Evrenzo) was the first orally administered hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) for treating anemia of chronic kidney disease. To understand what is the meaning of Roxadustat, one must grasp its innovative mechanism for stimulating the body's natural response to low oxygen levels.